top of page

Laxxon Medical to Participate in 25th Annual Needham Growth Conference

NEW YORK, NY / ACCESSWIRE / January 5, 2023 / Laxxon Medical Corporation announced today their invitation to participate as a private company in the 25th Annual Needham Growth Conference at the Lotte New York Palace Hotel on January 10-12, 2023.

Helmut Kerschbaumer, CEO/Chairman, and Alexander Ruckdaeschel, Chief Strategy Officer, will hold one-on-one meetings with institutional, private equity, and venture capital investors throughout the day on January 12, 2023.

About Laxxon Medical Corporation

Laxxon Medical is a pharma-technology company pioneering innovative 3D screen-printed pharmaceutical solutions through SPID®-Technology (Screen Printing Innovational Drug Technology), an additive 3D screen printing technology and manufacturing process. Laxxon Medical holds the exclusive worldwide rights to the use and application of SPID®-Technology for developing, manufacturing, and commercializing pharmaceutical dosage forms.

Investor Contact:

Alexander Ruckdaeschel Chief Strategy Director

Media Contact:

Frances Hoggard Communications Manager

See the original press release here.


Laxxon Medical is dedicated to engineering patented 3D pharmaceutical solutions which optimize products and benefit patients. We aim to establish SPID®-Technology as a manufacturing process with the individual and the pharmaceutical partner in mind.

To keep up to date with SPID®-Technology and Laxxon Medical news and announcements, follow us on Twitter and LinkedIn.

11 views0 comments
bottom of page